COVID-19 has led to delays in cancer screenings in countries like Australia, putting people at risk of poorer health outcomes due to late-stage diagnosis. As pandemic restrictions continue to ease, will there be a sudden rise in cancer cases and what could this mean for life insurers?
Comments
Remove Comment
Are you sure you want to delete your comment?
This cannot be undone.